|
1
|
Emery P, Durand B, Mach B and Reith W: RFX
proteins, a novel family of DNA binding proteins conserved in the
eukaryotic kingdom. Nucleic Acids Res. 24:803–807. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Aftab S, Semenec L, Chu JS and Chen N:
Identification and characterization of novel human tissue-specific
RFX transcription factors. BMC Evol Biol. 8:2262008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Steimle V, Durand B, Barras E, Zufferey M,
Hadam MR, Mach B and Reith W: A novel DNA-binding regulatory factor
is mutated in primary MHC class II deficiency (bare lymphocyte
syndrome). Genes Dev. 9:1021–1032. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Durand B, Kobr M, Reith W and Mach B:
Functional complementation of major histocompatibility complex
class II regulatory mutants by the purified X-box-binding protein
RFX. Mol Cell Biol. 14:6839–6847. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Garvie CW and Boss JM: Assembly of the RFX
complex on the MHCII promoter: Role of RFXAP and RFXB in relieving
autoinhibition of RFX5. Biochim Biophys Acta. 1779:797–804. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Moreno CS, Beresford GW, Louis-Plence P,
Morris AC and Boss JM: CREB regulates MHC class II expression in a
CIITA-dependent manner. Immunity. 10:143–151. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hanna S and Etzioni A: MHC class I and II
deficiencies. J Allergy Clin Immunol. 134:269–275. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ting JP and Trowsdale J: Genetic control
of MHC class II expression. Cell. 109:(Suppl). S21–S33. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gobin SJ, Peijnenburg A, van Eggermond M,
van Zutphen M, van den Berg R and van den Elsen PJ: The RFX complex
is crucial for the constitutive and CIITA-mediated transactivation
of MHC class I and beta2-microglobulin genes. Immunity. 9:531–541.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sengupta PK, Fargo J and Smith BD: The RFX
family interacts at the collagen (COL1A2) start site and represses
transcription. J Biol Chem. 277:24926–24937. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Di Giacopo R, Cianetti L, Caputo V, La
Torraca I, Piemonte F, Ciolfi A, Petrucci S, Carta C, Mariotti P,
Leuzzi V, et al: Protracted late infantile ceroid lipofuscinosis
due to TPP1 mutations: Clinical, molecular and biochemical
characterization in three sibs. J Neurol Sci. 356:65–71. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sleat DE, Donnelly RJ, Lackland H, Liu CG,
Sohar I, Pullarkat RK and Lobel P: Association of mutations in a
lysosomal protein with classical late-infantile neuronal ceroid
lipofuscinosis. Science. 277:1802–1805. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
ENCODE Project Consortium, . A user's
guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol.
2011.http://dx.doi.org/10.1371/journal.pbio.1001046Accessed
April 19, 2011.
|
|
14
|
Mardis ER: ChIP-seq: Welcome to the new
frontier. Nat Methods. 4:613–614. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dunham I, Kundaje A, Aldred SF, Collins
PJ, Davis CA, Doyle F, Epstein CB, Frietze S, Harrow J, Kaul R, et
al: ENCODE Project Consortium: An integrated encyclopedia of DNA
elements in the human genome. Nature. 489:57–74. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Maher B: ENCODE: The human encyclopaedia.
Nature. 489:46–48. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
ENCODE Project Consortium, . The ENCODE
(ENCyclopedia of DNA elements) project. Science. 306:636–640. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Krawczyk M, Seguín-Estévez Q, Leimgruber
E, Sperisen P, Schmid C, Bucher P and Reith W: Identification of
CIITA regulated genetic module dedicated for antigen presentation.
PLoS Genet. 4:e10000582008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Westerheide SD, Louis-Plence P, Ping D, He
XF and Boss JM: HLA-DMA and HLA-DMB gene expression functions
through the conserved S-X-Y region. J Immunol. 158:4812–4821.
1997.PubMed/NCBI
|
|
20
|
Nekrep N, Fontes JD, Geyer M and Peterlin
BM: When the lymphocyte loses its clothes. Immunity. 18:453–457.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Paterson AC, Sciot R, Kew MC, Callea F,
Dusheiko GM and Desmet VJ: HLA expression in human hepatocellular
carcinoma. Br J Cancer. 57:369–373. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xie XW, Mei MH, Liao WJ, Qian LH, Yu X,
Fei R, Qin LL, Zhang HH, Peng JR, Shen DH, et al: Expression of
CIITA-related MHCII molecules in tumors linked to prognosis in
hepatocellular carcinoma. Int J Oncol. 34:681–688. 2009.PubMed/NCBI
|
|
23
|
Sung CH, Hu CP, Hsu HC, Ng AK, Chou CK,
Ting LP, Su TS, Han SH and Chang CM: Expression of class I and
class II major histocompatibility antigens on human hepatocellular
carcinoma. J Clin Invest. 83:421–429. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wong D, Lee W, Humburg P, Makino S, Lau E,
Naranbhai V, Fairfax BP, Chan K, Plant K and Knight JC: Genomic
mapping of the MHC transactivator CIITA using an integrated
ChIP-seq and genetical genomics approach. Genome Biol. 15:4942014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Villard J, Reith W, Barras E, Gos A,
Morris MA, Antonarakis SE, Van den Elsen PJ and Mach B: Analysis of
mutations and chromosomal localisation of the gene encoding RFX5, a
novel transcription factor affected in major histocompatibility
complex class II deficiency. Hum Mutat. 10:430–435. 1997.
View Article : Google Scholar : PubMed/NCBI
|
